Renu B. Lal

Renu B. Lal

Auto-generated profile, based on publicly available information

Renu B. Lal

International Centre for Diarrhoeal Disease Research Bangladesh, Dhaka, Bangladesh

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2014 in Bulletin of the World Health Organization
Verified
Journal Article
Closed access
SSSiddhartha Saha
Siddhartha Saha
MCMandeep Chadha
Mandeep Chadha
AMAbdullah Al Mamun
Abdullah Al Mamun
MRMahmudur Rahman
Mahmudur Rahman
KSKatharine Sturm-Ramirez
Katharine Sturm-Ramirez
RLRenu B Lal
Renu B Lal
To characterize influenza seasonality and identify the best time of the year for vaccination against influenza in tropical and subtropical countries of southern and south-eastern Asia that lie north of the equator. Weekly influenza surveillance data for 2006 to 2011 were obtained from Bangladesh, Cambodia, India, Indonesia, the Lao People's Democratic Republic, Malaysia, the Philippines, Singapore, Thailand and Viet Nam. Weekly rates of influenza activity were based on the percentage of all nasopharyngeal samples collected during the year that tested positive for influenza virus or viral nucleic acid on any given week. Monthly positivity rates were then calculated to define annual peaks of influenza activity in each country and across countries. Influenza activity peaked between June/July and October in seven countries, three of which showed a second peak in December to February. Countries closer to the equator had year-round circulation without discrete peaks. Viral types and subtypes varied from year to year but not across countries in a given year. The cumulative proportion of specimens that tested positive from June to November was > 60% in Bangladesh, Cambodia, India, the Lao People's Democratic Republic, the Philippines, Thailand and Viet Nam. Thus, these tropical and subtropical countries exhibited earlier influenza activity peaks than temperate climate countries north of the equator. Most southern and south-eastern Asian countries lying north of the equator should consider vaccinating against influenza from April to June; countries near the equator without a distinct peak in influenza activity can base vaccination timing on local factors.

1 January 1998 in Virology
Verified
Journal Article
Closed access
PDF file
Lihua XiaoLihua Xiao
Lihua Xiao
SOSherry M. Owen
Sherry M. Owen
IGIra Goldmana
Ira Goldmana
ALAltaf A. Lal
Altaf A. Lal
JDJacques J. Dejong
Jacques J. Dejong
RLRenu B. Lal
Renu B. Lal

1 July 1998 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
SOSherry M. Owen
Sherry M. Owen
DEDennis Ellenberger
Dennis Ellenberger
MRMark Rayfield
Mark Rayfield
SWStefan Wiktor
Stefan Wiktor
PMPhilippe Michel
Philippe Michel
RLRenu B. Lal
Renu B. Lal
Several members of the seven-transmembrane chemokine receptor family have been shown to serve, with CD4, as coreceptors for entry by human immunodeficiency virus type 1 (HIV-1). While coreceptor usage by HIV-1 primary isolates has been studied by several groups, there is only limited information available concerning coreceptor usage by primary HIV-2 isolates. In this study, we have analyzed coreceptor usage of 15 primary HIV-2 isolates, using lymphocytes from a donor with nonfunctional CCR5 (CCR5 −/−; homozygous 32-bp deletion). Based on the infections of PBMCs, seven of these primary isolates had an absolute requirement for CCR5 expression, whereas the remaining eight exhibited a broader coreceptor usage. All CCR5-requiring isolates were non-syncytium inducing, whereas isolates utilizing multiple coreceptors were syncytium inducing. Blocking experiments using known ligands for chemokine receptors provided indirect evidence for additional coreceptor utilization by primary HIV-2 isolates. Analysis of GHOST4 cell lines expressing various chemokine receptors (CCR1, CCR2b, CCR3, CCR4, CCR5, CXCR4, BONZO, and BOB) further defined specific coreceptor usage of primary HIV-2 isolates. The receptors used included CXCR4, CCR1-5, and the recently described receptors BONZO and BOB. However, the efficiency at which the coreceptors were utilized varied greatly among the various isolates. Analysis of V3 envelope sequences revealed no specific motif that correlated with coreceptor usage. Our data demonstrate that primary HIV-2 isolates are capable of using a broad range of coreceptors for productive infection in vitro. Additionally, our data suggest that expanded coreceptor usage by HIV-2 may correlate with disease progression.

1 August 1999 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
CYChunfu Yang
Chunfu Yang
DPDanuta Pieniazek
Danuta Pieniazek
SOSherry M. Owen
Sherry M. Owen
CFCarol Fridlund
Carol Fridlund
JNJohn Nkengasong
John Nkengasong
RLRenu B. Lal
Renu B. Lal
The high degree of genetic diversity within human immunodeficiency virus type 1 (HIV-1), which includes two major groups, M (major) and O (outlier), and various env subtypes within group M (subtypes A to J), has made designing assays that will detect all known HIV-1 strains difficult. We have developed a generic primer set based on the conserved immunodominant region of transmembrane protein gp41 that can reliably amplify as few as 10 copies/PCR of viral DNA from near-full-length clones representing group M subtypes A to H (subtypes I and J were not available). The assay is highly sensitive in detecting plasma viral RNA from HIV-1 strains of diverse geographic origins representing different subtypes of HIV-1 group M as well as HIV-1 group O. Of the 253 group M plasma specimens (subtypes A, 68 specimens; B, 71; C, 19; D, 27; E, 23; F, 33; and G, 12), 250 (98.8%) were amplified by using the gp41 M/O primer set. More importantly, all 32 (100%) group O plasma samples were also amplified with these primers. In vitro spiking experiments further revealed that the assay could reliably detect as few as 25 copies/ml of viral RNA and gave positive signals in HIV-1-seropositive specimens with plasma copy numbers below the limits of detection by all commercially available viral load assays. In addition, analysis of five seroconversion panels indicated that the assay is highly sensitive for early detection of plasma viremia during the “window period.” Thus, the highly sensitive assay will be useful for early detection of HIV-1 in clinical specimens from all known HIV-1 infections, regardless of their genotypes and geographic origins.

15 June 2000 in Journal of Virology
Verified
Journal Article
Open access
PDF file
SOSherry M. Owen
Sherry M. Owen
SMSilvina Masciotra
Silvina Masciotra
FNFrank Novembre
Frank Novembre
JYJoAnn Yee
JoAnn Yee
WSWilliam M. Switzer
William M. Switzer
RLRenu B. Lal
Renu B. Lal
Primary simian immunodeficiency virus (SIV) isolated from sooty mangabey (SIVsm [ n = 6]), stumptail (SIVstm [ n = 1]), mandrill (SIVmnd [ n = 1]), and African green (SIVagm [ n = 1]) primates were examined for their ability to infect human cells and for their coreceptor requirements. All isolates infected human peripheral blood mononuclear cells (PBMCs) from a CCR5 +/+ donor, and seven of eight isolates tested also infected CCR5 −/− PBMCs. Analysis of coreceptor utilization using GHOST and U87 cell lines revealed that all of the isolates tested used CCR5 and the orphan receptors STRL33 and GPR15. Coreceptors such as CCR2b, CCR3, CCR8, and CX3CR1 were also utilized by some primary SIV isolates. More importantly, we found that CXCR4 was used as a coreceptor by the SIVstm, the SIVagm, and four of the SIVsm isolates in GHOST and U87 cells. These data suggest that primary SIV isolates from diverse primate species can utilize CXCR4 for viral entry, similar to what has been described for human immunodeficiency viruses.

1 May 2000 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
CYChunfu Yang
Chunfu Yang
BDBipin C. Dash
Bipin C. Dash
FSFrançois Simon
François Simon
GGGuido van der Groen
Guido van der Groen
DPDanuta Pieniazek
Danuta Pieniazek
RLRenu B. Lal
Renu B. Lal
Human immunodeficiency virus type 1 (HIV-1) infection of humans is the result of independent cross-species transmissions of simian immunodeficiency viruses (SIVcpz) from naturally infected chimpanzees (Pan troglodytes troglodytes) to man. To develop a polymerase chain reaction—based assay capable of detecting members of all major phylogenetic SIVcpz and HIV-1 lineages (groups M, N, and O), primer pairs in conserved pol and env regions were designed. Both primer sets amplified ⩽ 10 copies of selected group M reference clones (subtypes A–H), proviral DNA or RNA of group N (YBF30), and group O of HIV-1 and also amplified divergent SIVcpz from cultured isolates (SIVcpzGAB1 and SIVcpzANT), uncultured spleen tissue (SIVcpzUS), and plasma (SIVcpzANT and SIVcpzUS). Sequences of the 2 amplicons (445 bp for gp41 and 261 bp for integrase) are of sufficient length for phylogenetic analyses, allowing both group and subtype classifications of the human viruses. Finally, both primer pairs are highly sensitive (>99%) in amplifying viral sequences from plasma taken from patients infected with HIV-1 group M (n = 226) and O (n = 17) viruses.